• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION PERCUFLEX URETERAL STENT; CATHETER, BILIARY, DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION PERCUFLEX URETERAL STENT; CATHETER, BILIARY, DIAGNOSTIC Back to Search Results
Device Problem Obstruction of Flow (2423)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/01/2014
Event Type  malfunction  
Manufacturer Narrative
Lock b3: approximated based on the year the first procedures were performed.Block d4, h4: the complainant was unable to provide the suspect device lot number; therefore, the lot expiration and device manufacture dates are unknown.Block e1: initial reporter facility name: (b)(6) hospital block g2 (literature source): journal article: orel carmona, et al, 'unveiling the challenges in tandem ureteral stent management for malignant ureteral obstruction: failure rate, risk factors, and durability of their replacement'.J.Clin.Med 2023, 12, 5251 block h6: imdrf device code a1409 captures the reportable event of stent obstructed.
 
Event Description
Boston scientific corporation became aware of the event through the article "unveiling the challenges in tandem ureteral stent management for malignant ureteral obstruction: failure rate, risk factors, and durability of their replacement", orel carmona, asaf shvero, dorit e.Zilberman, zohar a.Dotan, and nir kleinmann.Per the article, 186 patients being treated for malignant ureteral obstruction (muo) received 240 tandem ureteral stent (tus) placements.The patients underwent stenting between 2014 and 2022, then replacement procedures after 12 months.Follow up visits were performed 1 month after stenting then every 2 months thereafter.During the procedures, 2 stents would be placed simultaneously over guidewire under fluoroscopy.The procedures were performed under general anesthesia in the dorsal lithotomy position.In 67 patients, drainage of the stent failed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCUFLEX URETERAL STENT
Type of Device
CATHETER, BILIARY, DIAGNOSTIC
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
2546 calle primera
alajuela
CS  
Manufacturer Contact
farshad fahimi
4100 hamline avenue north
building c
saint paul, MN 55112
MDR Report Key18735984
MDR Text Key336746020
Report Number2124215-2024-08934
Device Sequence Number1
Product Code FGE
Combination Product (y/n)N
Reporter Country CodeIS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Literature
Reporter Occupation Physician
Type of Report Initial
Report Date 02/19/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/19/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/25/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-